UnitedHealth Group Incorporated (NYSE:UNH) Holdings Cut by Seilern Investment Management Ltd

Seilern Investment Management Ltd lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 263,098 shares of the healthcare conglomerate's stock after selling 39,386 shares during the period. UnitedHealth Group accounts for 9.0% of Seilern Investment Management Ltd's holdings, making the stock its 2nd biggest holding. Seilern Investment Management Ltd's holdings in UnitedHealth Group were worth $137,798,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC lifted its holdings in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the period. Raymond James Financial Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at $1,914,740,000. Amundi lifted its holdings in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. HSBC reiterated a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a report on Thursday, May 15th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $428.43.

UnitedHealth Group Stock Up 2.5%

UNH stock traded up $7.40 during trading on Friday, reaching $303.24. The stock had a trading volume of 12,558,756 shares, compared to its average volume of 7,009,546. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company's 50 day moving average is $409.03 and its two-hundred day moving average is $483.40. The company has a market capitalization of $275.08 billion, a price-to-earnings ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the company posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 in the last three months. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.